These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

921 related items for PubMed ID: 17494965

  • 1. Preparation and characterization of cationic chitosan-modified poly(D,L-lactide-co-glycolide) copolymer nanospheres as DNA carriers.
    Guan XP, Quan DP, Liao KR, Tao Wang, Peng Xiang, Mai KC.
    J Biomater Appl; 2008 Jan; 22(4):353-71. PubMed ID: 17494965
    [Abstract] [Full Text] [Related]

  • 2. Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides.
    Nafee N, Taetz S, Schneider M, Schaefer UF, Lehr CM.
    Nanomedicine; 2007 Sep; 3(3):173-83. PubMed ID: 17692575
    [Abstract] [Full Text] [Related]

  • 3. Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing.
    Zeng P, Xu Y, Zeng C, Ren H, Peng M.
    Int J Pharm; 2011 Aug 30; 415(1-2):259-66. PubMed ID: 21645597
    [Abstract] [Full Text] [Related]

  • 4. Hybrid-modified poly(D,L-lactide-co-glycolide) nanospheres for a novel cellular drug delivery system.
    Tahara K, Furukawa S, Yamamoto H, Kawashima Y.
    Int J Pharm; 2010 Jun 15; 392(1-2):311-3. PubMed ID: 20347023
    [Abstract] [Full Text] [Related]

  • 5. Oral nuclear factor-κB decoy oligonucleotides delivery system with chitosan modified poly(D,L-lactide-co-glycolide) nanospheres for inflammatory bowel disease.
    Tahara K, Samura S, Tsuji K, Yamamoto H, Tsukada Y, Bando Y, Tsujimoto H, Morishita R, Kawashima Y.
    Biomaterials; 2011 Jan 15; 32(3):870-8. PubMed ID: 20934748
    [Abstract] [Full Text] [Related]

  • 6. Spray-drying preparation of microparticles containing cationic PLGA nanospheres as gene carriers for avoiding aggregation of nanospheres.
    Takashima Y, Saito R, Nakajima A, Oda M, Kimura A, Kanazawa T, Okada H.
    Int J Pharm; 2007 Oct 01; 343(1-2):262-9. PubMed ID: 17628365
    [Abstract] [Full Text] [Related]

  • 7. Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles.
    Niu X, Zou W, Liu C, Zhang N, Fu C.
    Drug Dev Ind Pharm; 2009 Nov 01; 35(11):1375-83. PubMed ID: 19832638
    [Abstract] [Full Text] [Related]

  • 8. Accelerating thrombolysis with chitosan-coated plasminogen activators encapsulated in poly-(lactide-co-glycolide) (PLGA) nanoparticles.
    Chung TW, Wang SS, Tsai WJ.
    Biomaterials; 2008 Jan 01; 29(2):228-37. PubMed ID: 17953984
    [Abstract] [Full Text] [Related]

  • 9. The intracellular uptake ability of chitosan-coated Poly (D,L-lactide-co-glycolide) nanoparticles.
    Kim BS, Kim CS, Lee KM.
    Arch Pharm Res; 2008 Aug 01; 31(8):1050-4. PubMed ID: 18787796
    [Abstract] [Full Text] [Related]

  • 10. Preparation and characterization of cationic PLGA nanospheres as DNA carriers.
    Ravi Kumar MN, Bakowsky U, Lehr CM.
    Biomaterials; 2004 May 01; 25(10):1771-7. PubMed ID: 14738840
    [Abstract] [Full Text] [Related]

  • 11. Photochemical internalization for pDNA transfection: evaluation of poly(d,l-lactide-co-glycolide) and poly(ethylenimine) nanoparticles.
    Gargouri M, Sapin A, Arıca-Yegin B, Merlin JL, Becuwe P, Maincent P.
    Int J Pharm; 2011 Jan 17; 403(1-2):276-84. PubMed ID: 21044878
    [Abstract] [Full Text] [Related]

  • 12. Fabrication and characterization of PLGA/HAp composite scaffolds for delivery of BMP-2 plasmid DNA.
    Nie H, Wang CH.
    J Control Release; 2007 Jul 16; 120(1-2):111-21. PubMed ID: 17512077
    [Abstract] [Full Text] [Related]

  • 13. Improved cellular uptake of chitosan-modified PLGA nanospheres by A549 cells.
    Tahara K, Sakai T, Yamamoto H, Takeuchi H, Hirashima N, Kawashima Y.
    Int J Pharm; 2009 Dec 01; 382(1-2):198-204. PubMed ID: 19646519
    [Abstract] [Full Text] [Related]

  • 14. Effect of preparative variables on small interfering RNA loaded Poly(D,L-lactide-co-glycolide)-chitosan submicron particles prepared by emulsification diffusion method.
    Katas H, Chen S, Osamuyimen AA, Cevher E, Oya Alpar H.
    J Microencapsul; 2008 Dec 01; 25(8):541-8. PubMed ID: 18465303
    [Abstract] [Full Text] [Related]

  • 15. Encapsulation of 9-nitrocamptothecin, a novel anticancer drug, in biodegradable nanoparticles: factorial design, characterization and release kinetics.
    Derakhshandeh K, Erfan M, Dadashzadeh S.
    Eur J Pharm Biopharm; 2007 Apr 01; 66(1):34-41. PubMed ID: 17070678
    [Abstract] [Full Text] [Related]

  • 16. Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content.
    Budhian A, Siegel SJ, Winey KI.
    Int J Pharm; 2007 May 24; 336(2):367-75. PubMed ID: 17207944
    [Abstract] [Full Text] [Related]

  • 17. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
    Yadav AK, Mishra P, Mishra AK, Mishra P, Jain S, Agrawal GP.
    Nanomedicine; 2007 Dec 24; 3(4):246-57. PubMed ID: 18068091
    [Abstract] [Full Text] [Related]

  • 18. Cellular uptake mechanisms and intracellular distributions of polysorbate 80-modified poly (D,L-lactide-co-glycolide) nanospheres for gene delivery.
    Tahara K, Yamamoto H, Kawashima Y.
    Eur J Pharm Biopharm; 2010 Jun 24; 75(2):218-24. PubMed ID: 20332026
    [Abstract] [Full Text] [Related]

  • 19. Surface modification of mitoxantrone-loaded PLGA nanospheres with chitosan.
    Chen H, Yang W, Chen H, Liu L, Gao F, Yang X, Jiang Q, Zhang Q, Wang Y.
    Colloids Surf B Biointerfaces; 2009 Oct 15; 73(2):212-8. PubMed ID: 19545985
    [Abstract] [Full Text] [Related]

  • 20. Particle size control of poly(dl-lactide-co-glycolide) nanospheres for sterile applications.
    Tsukada Y, Hara K, Bando Y, Huang CC, Kousaka Y, Kawashima Y, Morishita R, Tsujimoto H.
    Int J Pharm; 2009 Mar 31; 370(1-2):196-201. PubMed ID: 19100320
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.